Natural history of liver disease in a large international cohort of children with Alagille syndrome: Results from the GALA studyShannon M. Vandriel, Catherine Larson‐Nath, David A. Piccoli et al.|Hepatology|2022Cited by 91
Event-free survival of maralixibat-treated patients with Alagille syndrome compared to a real-world cohort from GALABettina E. Hansen, Shannon M. Vandriel, Pamela Vig et al.|Hepatology|2023Cited by 33
Clinical features and natural history of 1154 Alagille syndrome patients: results from the international multicenter GALA study groupShannon M. Vandriel, Pınar Bulut, Liting Li et al.|Journal of Hepatology|2020Cited by 10
CLINICAL FEATURES AND OUTCOMES IN AN INTERNATIONAL COHORT OF 731 ALAGILLE SYNDROME PATIENTS FROM 19 COUNTRIESShannon M. Vandriel, Binita M. Kamath, Jian‐She Wang et al.|DIAL (Catholic University of Leuven)|2019Cited by 6
Phenotypic Divergence of <i>JAG1</i> ‐ and <i>NOTCH2</i> ‐Associated Alagille Syndrome & Disease‐Specific <i>NOTCH2</i> Variant Classification GuidelinesShannon M. Vandriel, Chatmanee Lertudomphonwanit, Liting Li et al.|Liver International|2025Cited by 4